109 related articles for article (PubMed ID: 7762493)
1. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
[TBL] [Abstract][Full Text] [Related]
2. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
3. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
[TBL] [Abstract][Full Text] [Related]
4. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina.
Gibbs JS; McAlpine HM; Wright C; McLenachan JM; Sparrow J; Sutton G; Dargie HJ; Fox KM
Int J Cardiol; 1991 Jun; 31(3):281-6. PubMed ID: 1879977
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
Weiner DA; Klein MD; Cutler SS
Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
[TBL] [Abstract][Full Text] [Related]
6. Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina.
Cutler NR; Eff J; Fromell G; Brass EP; Archer S; Chrysant SG; Fiddes R
J Clin Pharmacol; 1995 Feb; 35(2):189-95. PubMed ID: 7751431
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
Subramanian VB; Bowles MJ; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
[TBL] [Abstract][Full Text] [Related]
8. Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina.
Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
J Am Coll Cardiol; 1987 Mar; 9(3):615-21. PubMed ID: 3102585
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
Glasser SP; Gana TJ; Pascual LG; Albert KS
Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
[TBL] [Abstract][Full Text] [Related]
10. Verapamil therapy for stable exertional angina pectoris.
Weiner DA; Klein MD
Am J Cardiol; 1982 Nov; 50(5):1153-7. PubMed ID: 6814225
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy.
Weiner DA; McCabe CH; Cutler SS; Creager MA; Ryan TJ; Klein MD
Am J Cardiol; 1983 May; 51(8):1251-5. PubMed ID: 6342351
[TBL] [Abstract][Full Text] [Related]
12. Sustained-release and instant-release verapamil in treatment of angina pectoris.
Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB
Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226
[TBL] [Abstract][Full Text] [Related]
14. Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise.
Subramanian VB; Lahiri A; Paramasivan R; Raftery EB
Lancet; 1980 Apr; 1(8173):841-4. PubMed ID: 6103208
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
Chaitman BR
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
[TBL] [Abstract][Full Text] [Related]
16. An objective comparison of verapamil and placebo in chronic stable angina.
Balasubramanian V; Raftery EB
Clin Exp Pharmacol Physiol Suppl; 1982; 6():51-61. PubMed ID: 6811177
[TBL] [Abstract][Full Text] [Related]
17. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
Foale RA; Vandenburg MJ
Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
[TBL] [Abstract][Full Text] [Related]
18. Verapamil administered twice daily in stable angina pectoris.
Tan AT; Quek S
Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
[TBL] [Abstract][Full Text] [Related]
19. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
[TBL] [Abstract][Full Text] [Related]
20. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
Nordlander R; Walter M
Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
